ArticleThe journal of prevention of Alzheimer's disease2025
Erratum to "INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease" [J Prev Alzheimers Dis 2025;12(1): 100005.].
Eric Siemers et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.